{"id":5702,"date":"2020-03-09T15:39:39","date_gmt":"2020-03-09T14:39:39","guid":{"rendered":"http:\/\/www.seventure.fr\/wp-content\/uploads\/2020\/03\/4-NovoBind-Series-A-PR-20200218-1.pdf"},"modified":"2020-03-09T15:39:39","modified_gmt":"2020-03-09T14:39:39","slug":"4-novobind-series-a-pr-20200218","status":"inherit","type":"attachment","link":"https:\/\/www.seventure.fr\/en\/seventure-partners-invests-in-novobind-the-vancouver-headquartered-animal-health-biologics-business\/4-novobind-series-a-pr-20200218\/","title":{"rendered":"4 – NovoBind Series A PR 20200218"},"author":3,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false},"acf":[],"yoast_head":"\n